{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:56:55Z","timestamp":1767963415381,"version":"3.49.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050893","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T22:13:11Z","timestamp":1355350391000},"page":"e50893","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Laurent","family":"Azoulay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Themistocles L.","family":"Assimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee B.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"I Sipahi","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials","volume":"12","author":"S Bangalore","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref3","article-title":"FDA Drug Safety Communication: No increase in risk of cancer with certain blood pressure drugs\u2013Angiotensin Receptor Blockers (ARBs)","year":"2011","journal-title":"U S Food and Drug Administration"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.110.007336","article-title":"Use of angiotensin receptor blockers and the risk of cancer","volume":"123","author":"B Pasternak","year":"2011","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amjcard.2010.11.026","article-title":"Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension","volume":"107","author":"CC Huang","year":"2011","journal-title":"Am J Cardiol"},{"key":"ref6","article-title":"Long-term use of drugs affecting the renin-angiotensin system and the risk of cancer. A population-based case-control study","author":"J Hallas","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e2697","DOI":"10.1136\/bmj.e2697","article-title":"Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database","volume":"344","author":"K Bhaskaran","year":"2012","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK General Practice Research Database","volume":"350","author":"T Walley","year":"1997","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"LA Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","article-title":"Validation of information recorded on general practitioner based computerised data resource in the United Kingdom","volume":"302","author":"H Jick","year":"1991","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/pubmed\/21.3.299","article-title":"Clinical information for research; the use of general practice databases","volume":"21","author":"R Lawrenson","year":"1999","journal-title":"J Public Health Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2125.2000.00199.x","article-title":"Validation of the diagnosis of venous thromboembolism in general practice database studies","volume":"49","author":"R Lawrenson","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"SS Jick","year":"2003","journal-title":"Pharmacotherapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","article-title":"Calcium-channel blockers and risk of cancer","volume":"349","author":"H Jick","year":"1997","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001648-200101000-00015","article-title":"Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs","volume":"12","author":"LA Garcia-Rodriguez","year":"2001","journal-title":"Epidemiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/diacare.28.3.590","article-title":"Diabetes and the risk of lung cancer","volume":"28","author":"GC Hall","year":"2005","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10552-005-4705-5","article-title":"Prostate cancer risk among men with diabetes mellitus (Spain)","volume":"16","author":"A Gonzalez-Perez","year":"2005","journal-title":"Cancer Causes Control"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00125-011-2390-3","article-title":"Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data","volume":"55","author":"TP van Staa","year":"2012","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark","volume":"92","author":"S Friis","year":"2001","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(00)00674-4","article-title":"Is diuretic therapy associated with an increased risk of colon cancer?","volume":"110","author":"A Tenenbaum","year":"2001","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.amjcard.2011.06.031","article-title":"Immortal person time bias in pharmacoepidemiological studies of antihypertensive drugs","volume":"108","author":"TL Assimes","year":"2011","journal-title":"Am J Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"E1073","DOI":"10.1503\/cmaj.101497","article-title":"Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies","volume":"183","author":"C Yoon","year":"2011","journal-title":"CMAJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.0.CO;2-3","article-title":"Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses&apos; health study","volume":"83","author":"KB Michels","year":"1998","journal-title":"Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/pds.1656","article-title":"Long-term use of antihypertensive drugs and risk of cancer","volume":"17","author":"TL Assimes","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s10552-009-9374-3","article-title":"Age at incident treatment of hypertension and risk of cancer: a population study","volume":"20","author":"TL Assimes","year":"2009","journal-title":"Cancer Causes Control"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:52:06Z","timestamp":1540241526000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050893"}},"subtitle":[],"editor":[{"given":"Kin Mang","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050893","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}